Comparison of Clinical Presentation and Vaccine Effectiveness Among Omicron and Non-omicron SARS Coronavirus-2 Patients
Authors:
Open Access
- 8 December 2022
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 14 (12) , e32354
Abstract
The rapidly mutating Omicron SARS-CoV-2 variant has replaced the previous dominant SARS-CoV-2 variants like alpha, and delta resulting in the amplification of coronavirus disease 2019 (COVID-19) cases. The present study was conducted to compare the clinical profile and vaccination status in patients infected with Omicron and non-Omicron SARS-CoV-2 variants. All patients who tested positive for coronavirus disease 2019 (COVID-19) during the study period (January 2022 to February 2022) were further tested for detection of SARS-CoV-2 Omicron variant by using Omisure kit (TATA MD CHECK RT-PCR, TATA MEDICAL AND DIAGNOSTICS LIMITED, Tamil Nadu, INDIA). Clinico-demographic factors and vaccination status were compared between both Omicron and non-Omicron groups. A total of 1,722 patients who tested positive for COVID-19 were included in the study, of which 656 (38.1%) were Omicron and 1,066 (61.9%) were non-Omicron SARS-CoV-2 variants. Blood group and vaccination status were the major predictors for Omicron. The proportion of male patients was 58.4% in the Omicron group and 57.9% in the non-Omicron group. Maximum cases (86.2%) belonged to >18-60 years age group, 7.3% to >60 years age group, and least to 0-18 years (6.5%). The average age of the study participants was 35.4 ± 14.5 years. Vaccinated participants had less chance of having Omicron than the unvaccinated participants (p-value - 0.003). Fever and loss of smell were found to be significantly associated with the non-Omicron SARS-CoV-2 variant. (p-value < 0.05). The present study reflects that the clinical course of the disease is milder in Omicron as compared to the non-Omicron variant. However rapid rise in cases can badly affect the healthcare system demanding good preparedness to tackle all the predicaments. Good Vaccination coverage should be of utmost priority irrespective of the variant type.Keywords
This publication has 10 references indexed in Scilit:
- Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2Frontiers in Medicine, 2022
- Twin combination of Omicron and Delta variants triggering a tsunami wave of ever high surges in COVID‐19 cases: A challenging global threat with a special focus on the Indian subcontinentJournal of Medical Virology, 2022
- The emergence and epidemic characteristics of the highly mutated SARS‐CoV‐2 Omicron variantJournal of Medical Virology, 2022
- SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivoNature, 2022
- Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicityNature, 2022
- Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022Indian Journal of Medical Research, 2022
- Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastropheInfection, 2021
- Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: A population-based cross-sectional studyPLOS Medicine, 2021
- Association of ABO and Rh Blood Group in Susceptibility, Severity, and Mortality of Coronavirus Disease 2019: A Hospital-Based Study From Delhi, IndiaFrontiers in Cellular and Infection Microbiology, 2021
- Relationship of SARS-CoV-2 Pandemic with Blood GroupsTransfusion Medicine and Hemotherapy, 2021